Ingentec Corporation AI Stock Analysis
Ingentec Corporation (4768) AI Stock Analysis
Ingentec Corporation
(TPEx:4768)
Ingentec scores low primarily because strong revenue growth is not translating into profit — margins contracted by roughly two-thirds, net income fell 86%, and ROE sits near 1%. A debt-funded capacity build-out has lifted leverage above a 1:1 debt-to-equity ratio and driven free cash flow negative for a fifth year in six, raising financing and execution risk. Technicals compound the picture, with the share price far below all major moving averages and negative MACD confirming a persistent downtrend, even as oversold RSI and Stochastic readings hint at stretched selling. Valuation offers little cushion given negative earnings and a minimal 0.33% dividend yield. A re-rating would require evidence that new capacity restores margins and converts into positive free cash flow.
Ingentec Corporation (4768) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 14.29B
- Dividend Yield
- 0.29%
- Average Volume (3M)
- 532.49K
- Price to Earnings (P/E)
- -493.4
- Beta (1Y)
- 1.44
- Revenue Growth
- 118.90%
- EPS Growth
- -282.44%
- Country
- TW
- Employees
- 1,939
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Ingentec Corporation Business Overview & Revenue Model
Company Description
Ingentec Corp. engages in the manufacture and sale of fine chemicals, special materials and precision equipment. Its products include specialty gas, dry etching foundry service, semiconductor, flat panel display, printed circuit board, photovoltaic,...
Ingentec Corporation Financial Statement Overview
Summary
Revenue growth remains strong (NT$1.23bn, +21% YoY), but profitability has collapsed: gross margin fell from 40.6% to 24.6%, operating margin from 19.7% to 3.1%, and net income dropped 86% to NT$19 million. The balance sheet is increasingly stretched, with debt nearly doubling to NT$1.57bn and debt-to-equity rising to 1.05, while ROE fell to just 1.2%. Operating cash flow held steady at NT$244 million, but heavy capex of roughly NT$567 million left free cash flow deeply negative (-NT$323 million) for a fifth year in six, keeping the company reliant on external funding. Income statement (44), balance sheet (47), and cash flow (41) scores all point to an expansion phase carrying above-average earnings and leverage risk.
Income Statement
44NeutralBalance Sheet
47NeutralCash Flow
41Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.71B | 1.23B | 1.02B | 815.21M | 1.09B | 700.38M |
| Gross Profit | 322.01M | 302.74M | 412.73M | 357.49M | 490.59M | 267.78M |
| EBITDA | 101.23M | 149.15M | 284.47M | 223.14M | 378.65M | 173.54M |
| Net Income | -30.96M | 18.69M | 131.23M | 108.31M | 215.02M | 67.76M |
Balance Sheet | ||||||
| Total Assets | 4.44B | 3.81B | 2.82B | 2.37B | 1.78B | 1.37B |
| Cash, Cash Equivalents and Short-Term Investments | 814.14M | 549.57M | 297.85M | 391.74M | 425.62M | 269.44M |
| Total Debt | 1.78B | 1.57B | 810.56M | 411.66M | 296.67M | 527.47M |
| Total Liabilities | 2.74B | 2.10B | 945.88M | 512.49M | 468.23M | 639.61M |
| Stockholders Equity | 1.42B | 1.50B | 1.66B | 1.68B | 1.15B | 612.59M |
Cash Flow | ||||||
| Free Cash Flow | -135.93M | -322.86M | -333.11M | -16.51M | 73.39M | -194.39M |
| Operating Cash Flow | 435.03M | 243.94M | 249.26M | 239.78M | 338.68M | 21.72M |
| Investing Cash Flow | -529.33M | -552.60M | -537.22M | -843.89M | -267.84M | -217.50M |
| Financing Cash Flow | 605.42M | 572.58M | 247.07M | 504.42M | 85.91M | 325.30M |
Ingentec Corporation Peers Comparison
Overall Rating
TW:476459Neutral
TW:475558Neutral
TW:470745Neutral
TW:476842Neutral
TW:171039Underperform
TW:172739Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 59Neutral | TWD 11.49B | 42.72 | ― | 0.76% | 17.96% | 211.40% | |
| 58Neutral | TWD 12.34B | 27.45 | ― | 3.05% | -11.09% | 37.46% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 45Neutral | TWD 11.15B | 21.39 | ― | 0.92% | -9.16% | 67.21% | |
| 42Neutral | TWD 14.22B | -493.44 | ― | 0.29% | 118.90% | -282.44% | |
| 39Underperform | TWD 13.95B | -20.30 | ― | ― | -13.29% | -157.29% | |
| 39Underperform | TWD 11.75B | 121.53 | ― | 0.18% | 20.16% | 962.24% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4768 | Ingentec Corporation | 289.00 | 64.49 | 28.72% | |
| TW:1710 | Oriental Union Chemical Corp. | 16.95 | 4.20 | 32.94% | |
| TW:1727 | Chung Hwa Chemical Industrial Works Ltd. | 84.10 | 47.51 | 129.83% | |
| TW:4707 | Pan Asia Chemical Corp. | 27.30 | 17.85 | 188.80% | |
| TW:4755 | San Fu Chemical Co., Ltd. | 121.50 | 17.34 | 16.65% | |
| TW:4764 | Double Bond Chemical Ind., Co., Ltd. | 131.00 | 63.18 | 93.16% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
